APTARGROUP, INC.
No SEC Form 4 filings for $ATR in the last 30 days.
See all $ATR insider activity →UBS initiated coverage on AptarGroup with a neutral rating and a $135 price target. The company's stock is currently trading at $121.81. Recent events include management changes and a presentation at the Wells Fargo Healthcare Conference.
Analysts made several rating changes: UBS upgraded Invesco (IVZ) to Buy with a $41 target, Raymond James initiated M&T Bank (MTB) as Outperform with a $250 target, Morgan Stanley upgraded Nexa Resources (NEXA) to Overweight, and others. KeyBanc upgraded Corteva (CTVA) to Overweight with a $17 target, Jefferies upgraded Ambiq Micro (AMBQ) to Buy with a $90 target, and Citi upgraded Flutter to Buy with a $91 target.
APTARGROUP, INC. (ATR) filed an SEC Form 8-K — Regulation FD Disclosure. Item 7.01 Regulation FD Disclosure AptarGroup, Inc. (the “Company”) takes note of the decree of the President of the Russian Federation, published on September 21, 2026, that places the Company’s Russian subsidiary, OOO Aptar Vladimir (“Aptar Vladimir”), under temporary external
Over the past 7 days, AlphAI's AI scored 1 news story mentioning ATR (APTARGROUP, INC.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent ATR coverage spans corporate actions, financial news and regulation.
UBS initiated coverage on AptarGroup with a neutral rating and a $135 price target. The company's stock is currently trading at $121.81. Recent events include management changes and a presentation at the Wells Fargo Healthcare Conference.
Buy rating may support price gains.
Potential impairment risk and operational uncertainty for a small portion of the business.
Russian President Vladimir Putin has placed a 100% stake in Aptar Vladimir, a subsidiary of AptarGroup, under temporary management. Aptar Vladimir operates a plastic packaging plant in Russia. The temporary manager, H&N, is the legal entity behind Danone's nationalized Russian division. AptarGroup is a U.S.-based multinational company.
Leadership change in finance may cause short‑term stock volatility and could affect investor perception of financial oversight.
AlphAI scores every news story that mentions ATR with an AI model for sentiment and relevance, and aggregates insider trades from APTARGROUP, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
UBS initiated coverage on AptarGroup with a neutral rating and a $135 price target. The company's stock is currently trading at $121.81. Recent events include management changes and a presentation at the Wells Fargo Healthcare Conference.
1 min readAnalysts made several rating changes: UBS upgraded Invesco (IVZ) to Buy with a $41 target, Raymond James initiated M&T Bank (MTB) as Outperform with a $250 target, Morgan Stanley upgraded Nexa Resources (NEXA) to Overweight, and others. KeyBanc upgraded Corteva (CTVA) to Overweight with a $17 target, Jefferies upgraded Ambiq Micro (AMBQ) to Buy with a $90 target, and Citi upgraded Flutter to Buy with a $91 target.
2 min readAPTARGROUP, INC. (ATR) filed an SEC Form 8-K — Regulation FD Disclosure. Item 7.01 Regulation FD Disclosure AptarGroup, Inc. (the “Company”) takes note of the decree of the President of the Russian Federation, published on September 21, 2026, that places the Company’s Russian subsidiary, OOO Aptar Vladimir (“Aptar Vladimir”), under temporary external
1 min readRussian President Vladimir Putin has placed a 100% stake in Aptar Vladimir, a subsidiary of AptarGroup, under temporary management. Aptar Vladimir operates a plastic packaging plant in Russia. The temporary manager, H&N, is the legal entity behind Danone's nationalized Russian division. AptarGroup is a U.S.-based multinational company.
2 min readAPTARGROUP, INC. (ATR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 4, 2026, Aditya J. Gandhi, Vice President, Chief Accounting Officer of AptarGroup, Inc. (the “Company”), noti
1 min readAPTARGROUP, INC. (ATR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 29, 2026, the Board of Directors (the “Board”) of AptarGroup, Inc. (the “Company”) increased the size of the Boa
1 min readTouya Gael (Segment Pres., CEO Designate) sold 3,740 shares of APTARGROUP, INC. (ATR) at an average of $133.76 ($133.69–$134.55, $0.50M total) across 2 trades on 2026-08-27.
1 min readForecast International data cited by fDi says global aircraft order backlog for Airbus, Boeing, Embraer and ATR was 16,832 at end-July 2026, up 4.7% from end-2025. Deliveries rose to 1,503 in 2025 and are on track for 1,425 in 2026. Iata expects no meaningful backlog improvement before 2030 due to supply-chain bottlenecks, engine constraints, tariffs and labour shortages.
6 min readSchroder Asian Total Return Investment Company plc (ATR) said it has published a circular for shareholders on a proposed combination with Pacific Assets Trust plc (PAC). The plan would use a scheme of reconstruction and PAC’s members’ voluntary winding-up, transferring most PAC assets and issuing New ATR shares. A cash option is capped at 25% with a 2% discount; shareholder approval is required.
6 min readAptarGroup (ATR) reported Q2 2026 total sales of $1.03B, up 6% reported, with adjusted EPS of $1.42 above guidance. Adjusted EBITDA was $213M, down 3%, and margins fell due to mix and operational issues in beauty. Pharma core sales grew 8% excluding emergency medicine destocking. Net debt was $1.2B, leverage 1.49x, and Q3 adjusted EPS guidance is $1.45 to $1.53.
6 min read
